Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results - Here's Why

The brokerage highlighted that network expansion, entry into high-end radiology and geographic diversification remain key growth drivers for Dr. Lal, though near-term risks include rising competition,...